The SUSTAIN 7 study by Novo showed semaglutide (0.5mg and 1.0mg) to be superior to dulaglutide (0.75mg and 1.5mg) in terms of HbA1c reduction and weight loss after 40 weeks
Ripe and raw papaya mixed with honey can be a good remedy for melasma
The standard escalation begins at 0.25 mg weekly for four weeks, then advances to 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mgwith four-week intervals between increases
None are FDA-approved for human use, and this article reports documented protocols for research models, not medical advice
[DOI] [PubMed] [Google Scholar] 148.Zhang K, Shen X, Wu J, Sakaki K, Saunders T, Rutkowski DT, et al
A more recent and much larger multicenter, population-based study published yesterday in JAMA Ophthalmology has revealed an elevated inherent relative risk (incidence rate ratio, 1.32) of NAION for those exposed to semaglutide thats much smaller than the 4.28-fold hazard ratio (HR) found in a study published last summer.1 This was a retrospective study across 14 databases (six administrative claims and eight electronic health records)
